Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LCH-III
2006-002388-15Phase 4Active
- Sponsor
- ARNAS Civico Di Cristina Benfratelli
- Start
- Mar 2012
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of methotrexate in Langerhans cell histiocytosis (LCH), sponsored by ARNAS Civico Di Cristina Benfratelli. Primary endpoint: Overall survival. Started Mar 2012; status: active.
02
Drugs
methotrexate
03
Conditions
Langerhans cell histiocytosis (LCH)
Beyond the preview
Go deeper on 2006-002388-15.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002388-15.